The Gross Margin of Lytix Biopharma AS (LYTIX.OL) is 542.55%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 542.55% |